Number of people suffering from chronic diseases like cancer are rising constantly and this is a major concern for the medical fraternity. This prevalence of such dreadful diseases can be attributed to multiple factors like sedentary lifestyle, consumption of junk food and rising level of pollution. Among several types of cancer, castrate-resistant prostate cancer (CRPC) is defined through progression of disease irrespective of androgen depletion therapy (ADT) and is likely to showcase a constant surge in levels of serum prostate-specific antigen. The resistance is seen after 2-3 years of occurrence.
Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis): https://www.absolutemarketsinsights.com/request_sample.php?id=1264
The growth of the global castration-resistant prostate cancer (CRPC) treatment market was immensely impacted due to the coronavirus pandemic. Collapse of the healthcare infrastructure across the globe resulted in unavailability of proper medical treatment due to overcrowded hospitals and specialty clinics with COVID patients.
One of the major factors that is driving the growth of the global castration-resistant prostate cancer (CRPC) treatment market is availability of highly effective hormonal therapy. Which is due to launching new drugs and approved drugs. Also the fact that advancement in terms of innovative medicines help this market grow.
Meanwhile the only important factor that dents the growth of the global castration-resistant prostate cancer (CRPC) treatment market is higher cost of this treatment. Not everyone can afford it and this impacts immensely. On the other hand, rising demand for effective treatment for life-threatening diseases is the reason why the global castration-resistant prostate cancer (CRPC) treatment market is forecasted to see rapid growth over the period of new few years.
In terms of revenue, the global castration-resistant prostate cancer (CRPC) treatment market was worth US$ 10.2 Bn in 2021, growing at an estimated CAGR of 9.6% over the forecast period.
Speak to our analyst in case of queries before buying this report: https://www.absolutemarketsinsights.com/enquiry_before_buying.php?id=1264
By Treatment Type, Immunotherapy segment will witness growth at fastest rate for The Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market in 2022
Immunotherapy is being preferred when treatment is done of mildly symptomatic or asymptomatic cancer, and this will help the segment grow rapidly.
Asia Pacific Region to witness fastest growth for this market Over the Forecast Period (2022 – 2030) in the Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market
The region of Asia Pacific will be seeing massive growth for this market owing to the highly populated countries like India and China. Number of people suffering from life threatening diseases like cancer in the region are rising each passing day.
Some of the major players operating in the global castration-resistant prostate cancer (CRPC) treatment market are listed below:
- Astellas Pharma Inc.
- Bayer AG
- Pfizer, Inc.
- Johnson & Johnson Services, Inc (Xian Janssen Pharmaceutical Ltd.)
- Sanofi
- Other Market Participants
View our exclusive press releases on Industry Global News24
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Segmentation
The global castration-resistant prostate cancer (CRPC) treatment market has been segmented by type, indication, route of administration, treatment type, end users which are further classified into respective countries:
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Type Outlook (Revenue, USD Million, 2015 - 2030)
- Metastatic CRPC (mCRPC)
- Non-Metastatic CRPC (nmCRPC)
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Indication Outlook (Revenue, USD Million, 2015 - 2030)
- Symptomatic
- Mildly Symptomatic
- Asymptomatic
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Route of Administration Outlook (Revenue, USD Million, 2015 - 2030)
- Oral
- Intravenous
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Treatment Outlook (Revenue, USD Million, 2015 - 2030)
- Hormonal Therapy
- Radiation Therapy
- External Beam Radiation Therapy
- Systematic Radiation Therapy
- Chemotherapy
- Immunotherapy
- Targeted Therapy
- Others
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market End User Outlook (Revenue, USD Million, 2015 - 2030)
- Hospitals
- Speciality Clinics
- Others
Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Regional Outlook (Revenue, USD Million, 2015 - 2030)
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Purchase the latest in-depth Castration-Resistant Prostate Cancer (CRPC) Treatment Market Report @ https://www.absolutemarketsinsights.com/checkout?id=1264
Browse more trending reports by Absolute Markets Insights:
Gamma Delta T Cell Cancer Therapy Market - https://www.absolutemarketsinsights.com/reports/Global-Gamma-Delta-T-Cell-Cancer-Therapy-Market-2022---2030-1084
Global Dendritic Cell Cancer Vaccine Immunotherapy Market - https://www.absolutemarketsinsights.com/reports/Global-Dendritic-Cell-Cancer-Vaccine-Immunotherapy-Market-2021-2029-1057
About Us:
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.com